Hemoncare PC
Brooklyn, New York 11235
0 studies enrolling now · 14 studies all time
What they study most
Breast Cancer, Breast Neoplasms, Colorectal Cancer, Lymphoma, Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Metastasis, Multiple Myeloma and Plasma Cell Neoplasm, Non-Small Cell Lung Cancer, Osteoporosis
Studies at this site
- Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer — Completed
- Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma — Stopped early
- Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy — Completed
- Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma — Status unconfirmed
- Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Status unconfirmed
- Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer — Completed
- Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer — Completed
- Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
- A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients — Completed
- Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma — Completed
- BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma — Status unconfirmed
- Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
- A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed
- An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer — Completed